Supplier profile
ROCHE Farmacêutica Química, LDA
Every public-sector award we hold for this supplier, across Portugal, from 26 Mar 2009 to 26 Sept 2026.
Awards won
196
all time
Attributed value
€43.7m
85 shared, unvalued
Buyers
26
public bodies
Active
2009–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Unidade Local de Saúde Santa Maria, E.P.E. | 90 | €4.8m |
| Centro Hospitalar Universitário de Lisboa Norte, E. P. E. | 16 | €875k |
| Centro Hospitalar Lisboa Norte, E. P. E. | 15 | €1.3m |
| Hospital de Santo Espírito da Ilha Terceira, E. P. E. R. | 15 | €4.5m |
| Centro Hospitalar Universitário Lisboa Norte, E. P. E. | 10 | €5.7m |
| Serviço de Saúde da Região Autónoma da Madeira; EPE | 9 | €5.3m |
| Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM) | 8 | €454k |
| Centro Hospitalar Lisboa Norte; EPE | 5 | €340k |
| Centro Hospitalar de Coimbra; E.P.E. | 3 | €534k |
| Unidade Local de Saúde Gaia/Espinho, E.P.E. | 3 | €1.8m |
What they win
Awards
Showing 76–100 of 196 awards we hold
- Portugal – Antineoplastic and immunomodulating agents – 2023/0491-PERTUZUMAB +TRASTUZUMAB [80 + 40 MG/ML; SOL INJ; FRS] ↗Unidade Local de Saúde Santa Maria, E.P.E.shared awardawarded 16 Jan 2025
- Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - OCRELIZUMAB [300 MG/ 10 ML; SOL INJ; FRS] (O1030) ↗Unidade Local de Saúde Santa Maria, E.P.E.shared awardawarded 16 Jan 2025
- Portugal – Blood products – 2023/0304 - EMICIZUMAB [150 MG/ 0,4 ML; SOL INJ; FRS] (E843) ↗Unidade Local de Saúde Santa Maria, E.P.E.shared awardawarded 16 Jan 2025
- Portugal – Blood products – 2023/0304 - EMICIZUMAB [30 MG/ML; 1 ML; SOL INJ; FRS] ↗Unidade Local de Saúde Santa Maria, E.P.E.shared awardawarded 16 Jan 2025
- Portugal – Antineoplastic and immunomodulating agents – 2023/0491-ATEZOLIZUMAB [1200 MG/ 20 ML; SOL INJ; FRS] (A5827) ↗Unidade Local de Saúde Santa Maria, E.P.E.shared awardawarded 16 Jan 2025
- Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - PERTUZUMAB + TRASTUZUMAB [60 + 60 MG/ML; SOL INJ; FRS] (P1659) ↗Unidade Local de Saúde Santa Maria, E.P.E.shared awardawarded 16 Jan 2025
- Portugal – Antineoplastic and immunomodulating agents – 2023/0491- OBINUTUZUMAB [25 MG/ML; 40 ML; SOL INJ; FRS] ↗Unidade Local de Saúde Santa Maria, E.P.E.shared awardawarded 16 Jan 2025
- Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - RITUXIMAB [120 MG/ ML; 11,7 ML; FRS] ↗Unidade Local de Saúde Santa Maria, E.P.E.shared awardawarded 16 Jan 2025
- Portugal – Antineoplastic and immunomodulating agents – 2023/0491-TRASTUZUMAB EMTANSINA [100 MG; PÓ CONC SOL INJ; FRS] ↗Unidade Local de Saúde Santa Maria, E.P.E.shared awardawarded 16 Jan 2025
- Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - POLATUZUMAB VEDOTINA [30 MG; PÓ CONC SOL INJ; FRS] ↗Unidade Local de Saúde Santa Maria, E.P.E.shared awardawarded 16 Jan 2025
- Portugal – Antineoplastic and immunomodulating agents – 2023/0491- TRASTUZUMAB [600 MG/ 5 ML; SOL INJ; SC; FRS] ↗Unidade Local de Saúde Santa Maria, E.P.E.shared awardawarded 16 Jan 2025
- Portugal – Antineoplastic and immunomodulating agents – 2023/491 - Medicamentos do foro oncológico e imunomoduladores (O995) ↗Unidade Local de Saúde Santa Maria, E.P.E.shared awardawarded 14 Sept 2024
- Portugal – Blood products – 2023/304 - Medicamentos do grupo 4: sangue (E842) ↗Unidade Local de Saúde Santa Maria, E.P.E.shared awardawarded 2 Aug 2024
- Portugal – Blood products – 2023/304 - Medicamentos do grupo 4: sangue ( E844) ↗Unidade Local de Saúde Santa Maria, E.P.E.shared awardawarded 1 Aug 2024
- Portugal – Various medicinal products – IMUNOMODULADORES - ATEZOLIZUMAB E OCRELIZUMAB - 1º SEMESTRE ↗Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)awarded 12 Apr 2024
- Portugal – Medicinal products for the nervous system – RISDIPLAM 60 MG PO P/ SOL ORAL, PARA 2024 ↗Unidade Local de Saúde Santa Maria, E.P.E.€2.1mawarded 21 Mar 2024
- Portugal – Antineoplastic and immunomodulating agents – 2023/491 - Medicamentos do foro oncológico e imunomoduladores (T1268) ↗Unidade Local de Saúde Santa Maria, E.P.E.shared awardawarded 20 Mar 2024
- Portugal – Antineoplastic and immunomodulating agents – 2023/491 - Medicamentos do foro oncológico e imunomoduladores (A5827) ↗Unidade Local de Saúde Santa Maria, E.P.E.shared awardawarded 20 Mar 2024
- Portugal – Antineoplastic and immunomodulating agents – 2023/491 -Medicamentos do foro oncológico e imunomoduladores (V953) ↗Unidade Local de Saúde Santa Maria, E.P.E.shared awardawarded 20 Mar 2024
- Portugal – Antineoplastic and immunomodulating agents – 2023/491 - Medicamentos do foro oncológico e imunomoduladores (A5827) ↗Unidade Local de Saúde Santa Maria, E.P.E.shared awardawarded 12 Mar 2024
- Portugal – Medicinal products for the nervous system – RISDIPLAM 60 MG PO P/ SOL ORAL ↗Unidade Local de Saúde Santa Maria, E.P.E.€691kawarded 12 Mar 2024
- Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – PERTUZUMAB 600 MG/ 10 ML + TRASTUZUMAB 600 MG/ 10 ML SOL INJ SC ↗Unidade Local de Saúde Santa Maria, E.P.E.€299kawarded 1 Mar 2024
- Portugal – Antineoplastic and immunomodulating agents – POLATUZUMAB VEDOTINA ↗Unidade Local de Saúde Santa Maria, E.P.E.€366kawarded 29 Feb 2024
- Portugal – Various medicinal products – ANTIVÍRICOS - 1º SEMESTRE ↗Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)awarded 26 Feb 2024
- Portugal – Various medicinal products – IMUNOMODULADORES - 1º SEMESTRE ↗Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)awarded 20 Feb 2024
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.